Good News for Main Street Could Mean Bad News for Wall Street 7/6/23
CNBC's "Last Call"
00:00
The FDA Approval of a Drug to Slow the Progression of Alzheimer's Disease
LVMH, the private equity firm, Elle Catterton are considering a potential IPO for German sandal maker Birkenstock. Bloomberg is reporting that the brand could be valued at more than $6 billion. The FDA moving to approve a drug called Lekimbe that considerably slows the progression of all timers.
Transcript
Play full episode
